Start here if you came for the practical answer — dose, timing, how long it takes, side effects, vs melatonin: Ashwagandha for Sleep, the complete guide.
Educational article. Not medical advice; talk to your doctor about your own situation, especially if you take any medication. We make a sleep formula that contains ashwagandha — our conflict of interest is described at the end, and this piece was written to be checkable, not comfortable.
Spend twenty minutes reading about ashwagandha anywhere people talk — and one fear shows up more than every other side effect combined. The words repeat across thousands of posts: emotionally flat. Nonchalant. Numb. "I stopped caring about things I care about." Some people describe it lifting days after they stop; a few describe months. Alongside them, just as real: people who took it for years and felt nothing but calmer.
So we did what we do with every question in this Journal: we went to the primary sources and counted.
The zero
On 15 September 2026, PubMed indexed 53 randomized controlled trials of ashwagandha (search: (withania somnifera) AND randomized controlled trial[pt]). Then we searched the entire database — not just trials, everything: case reports, reviews, letters — for the internet's biggest ashwagandha fear:
Read that carefully, because it cuts two ways. If you came here to hear "the numbness thing is a myth" — this is not that. And if you came to hear "the trials are hiding it" — it isn't that either. The honest reading is stranger: nobody has ever formally asked the question.
What the trials actually measured
The safety record in the literature is genuinely reassuring — as far as it goes. Three examples with the doses and durations spelled out:
- 64 adults, 300 mg twice daily, 60 days (PMID 23439798). Adverse effects "mild in nature and comparable in both groups"; no serious adverse events. Follow-up was a phone call on days 15, 30 and 45 asking about adverse reactions.
- 60 adults, 300 mg twice daily, 10 weeks, a sleep-and-anxiety trial (PMID 31728244) — same picture on safety.
- 80 healthy adults, 300 mg twice daily, 8 weeks, a trial designed specifically to test safety (PMID 33338583): blood counts, liver panels, thyroid function, vitals — all monitored.
Notice what's on that list — and what isn't. Bloodwork, liver enzymes, thyroid hormones, blood pressure: measured to the decimal. Emotional range, reactivity, the capacity to feel joy or grief at full volume: not an outcome in any of the 53 trials. Adverse events were collected the way they usually are — "have you noticed anything?" — and a subtle flattening of feeling is exactly the kind of thing that question misses. People report what hurts. Muted is not a symptom that raises its own hand.
Why both sides can be telling the truth
What follows is our reading — flagged as interpretation, not counted fact.
1. The trials never used the right instrument. Emotional blunting has validated questionnaires — they were built for antidepressant research, where the phenomenon is well documented. No ashwagandha trial has used one. Absence of evidence here is literally that: absence of anyone looking.
2. The durations don't overlap. Trials run 6–12 weeks. The most vivid anecdotes usually describe months or years of daily, uninterrupted use — often at unknown doses, in gummies, powders and blends stacked with other ingredients. The territory where the internet reports the problem is territory the studies have never entered.
3. Some of it may be the calm itself. Ashwagandha's measured effect is a reduction in stress reactivity — in the 60-day trial above, serum cortisol dropped significantly. If your drive, your edge, even your sense of who you are has been running on stress hormones for a decade, dialing that system down can genuinely read as "I don't care anymore." Same sensation, two descriptions: one person calls it healing, another calls it numbness. Both are reporting honestly.
4. And some of it is probably neither. Anecdote clusters grow by social contagion — the "ashwagandha made me emotionless" story became its own genre around 2022, and expectation shapes experience in both directions. That doesn't make any individual report false. It makes the pile of reports impossible to read as a rate.
What we do about it, since we sell the ingredient
Night Reset carries KSM-66® root extract at 600 mg — the dose range the trials above actually used (300 mg twice daily), taken at night rather than around the clock. That's a choice about staying inside the studied territory, not a claim of immunity. So here is our standing position, the same one printed on our safety page:
Calm is not flat. The point of this formula is to turn down the 3 a.m. alarm system — not to mute the rest of you. If you ever notice your feelings going quiet in a way you didn't ask for, stop. That's a real signal, not user error. If it doesn't lift within a few days of stopping, tell your doctor. And our guarantee covers exactly this, on night three or night sixty — you don't pay for a bottle that doesn't agree with you.
We'd rather lose a sale than argue with your own emotional weather. Your experience outranks our formula.
The bigger pattern
We've counted supplement labels all year, and this is the same lesson from a different angle. When we read 4,153 labels for their warning text, we found that labels warn about what's famous, not what's specific. The literature has its own version of that bias: trials measure what's easy to measure. Liver enzymes have a lab test; the volume knob on your emotional life doesn't. So the most-discussed side effect of one of the world's most-studied herbs sits in a blind spot — 53 trials on one side, thousands of unheard reports on the other, and nobody running the study that would connect them.
If you know of a trial we missed — one that measured emotional reactivity on ashwagandha with a validated scale — write to us and we will update this article and say so at the top. We've published corrections before. It's the whole point.
How we counted, so you can check us
PubMed, searched 15 September 2026. Trial count: (withania somnifera) AND randomized controlled trial[pt] — 53 results. Zero-result queries, run across all article types with both common names: ashwagandha AND "emotional blunting"; withania AND "emotional blunting"; ashwagandha AND anhedonia; withania AND anhedonia; ashwagandha AND apathy — 0 results each. Cited trials: PMID 23439798, 31728244, 33338583 — doses and durations as stated in their abstracts.
Disclosure, as every time: we sell a product containing ashwagandha, so "zero papers report this" flatters our shelf — which is exactly why we also told you the harder half: zero papers have looked. Weigh both accordingly. The trials cited were largely funded or supplied by ingredient manufacturers, which is the norm in this category and worth knowing.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is general education, not medical advice — decisions about supplements and medication belong with you and your doctor.